Gene · 10514
Papers1,449
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,449
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators. | Nutrients | 2023 | 37571268 | PubTator, text mining | PubMed |
| Nuclear Actin Polymerization Regulates Cell Epithelial-Mesenchymal Transition. | Adv Sci (Weinh) | 2023 | 37566765 | PubTator, text mining | PubMed |
| CARM1 arginine methyltransferase as a therapeutic target for cancer. | J Biol Chem | 2023 | 37536629 | PubTator, text mining | PubMed |
| Loss of ANCO1 Expression Regulates Chromatin Accessibility and Drives Progression of Early-Stage Triple-Negative Breast Cancer. | Int J Mol Sci | 2023 | 37511268 | PubTator, text mining | PubMed |
| Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review. | Int J Mol Sci | 2023 | 37511059 | PubTator, text mining | PubMed |
| Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level. | Dis Model Mech | 2023 | 37493341 | PubTator, text mining | PubMed |
| A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma. | Cells | 2023 | 37371047 | PubTator, text mining | PubMed |
| How Do Cancer-Related Mutations Affect the Oligomerisation State of the p53 Tetramerisation Domain? | Curr Issues Mol Biol | 2023 | 37367066 | PubTator, text mining | PubMed |
| Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer. | Int J Mol Sci | 2023 | 37298588 | PubTator, text mining | PubMed |
| An Update on Tamoxifen and the Chemo-Preventive Potential of Vitamin E in Breast Cancer Management. | J Pers Med | 2023 | 37240924 | PubTator, text mining | PubMed |
| Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?-A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children. | Int J Mol Sci | 2023 | 37240136 | PubTator, text mining | PubMed |
| Molecular basis and dual ligand regulation of tetrameric estrogen receptor α/14-3-3ζ protein complex. | J Biol Chem | 2023 | 37224961 | PubTator, text mining | PubMed |
| Elevated nuclear TDP-43 induces constitutive exon skipping. | bioRxiv | 2023 | 37215013 | PubTator, text mining | PubMed |
| Relationships between some transcription factors and concordantly expressed drought stress-related genes in bread wheat. | Saudi J Biol Sci | 2023 | 37206446 | PubTator, text mining | PubMed |
| ACKnowledging the role of the Activated-Cdc42 associated kinase (ACK) in regulating protein stability in cancer. | Small GTPases | 2023 | 37194323 | PubTator, text mining | PubMed |
| Rapid physiological and transcriptomic changes associated with oxygen delivery in larval anemonefish suggest a role in adaptation to life on hypoxic coral reefs. | PLoS Biol | 2023 | 37167194 | PubTator, text mining | PubMed |
| A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors. | Signal Transduct Target Ther | 2023 | 37160887 | PubTator, text mining | PubMed |
| CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations. | Cancer Res | 2023 | 37140427 | PubTator, text mining | PubMed |
| Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy. | Signal Transduct Target Ther | 2023 | 37130896 | PubTator, text mining | PubMed |
| Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. | Cell Mol Biol Lett | 2023 | 37085753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10514/papers?page=4